Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D and Celecoxib for Breast Cancer Prevention
NCT01769625Phase 2Completed
- Sponsor
- Hartford Hospital
- Start
- Jan 2009
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution, vitamin d in breast cancer, sponsored by Hartford Hospital. Started Jan 2009; status: completed.
02
Drugs
celecoxib oral solutionvitamin d
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01769625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01769625.